Development and Characterization of Monoclonal Antibodies Specific for Mouse and Human Fcγ Receptors.
about
FcγR requirements leading to successful immunotherapy.Regulation of Monoclonal Antibody Immunotherapy by FcγRIIB.Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?STING Activation Reverses Lymphoma-Mediated Resistance to Antibody Immunotherapy.Detection of Experimental and Clinical Immune Complexes by Measuring SHIP-1 Recruitment to the Inhibitory FcγRIIB.GA101 P329GLALA, a variant of obinutuzumab with abolished ADCC, ADCP and CDC function but retained cell death induction, is as efficient as rituximab in B-cell depletion and antitumor activity.Engineered hexavalent Fc proteins with enhanced Fc-gamma receptor avidity provide insights into immune-complex interactions
P2860
Q38615360-4F8C0677-15A8-4D54-9A81-A7804F95363FQ38752906-BA7A8D5C-5407-43D1-B790-90FF66F182C0Q42372842-5981F7DA-2CC9-4174-B620-F5731DFBF4EAQ47122380-B653459B-E591-4632-99EB-AC886D85C2EEQ48204990-2E482549-BF61-49C7-9B7E-7A71D2FE709CQ49168895-5F586668-5D4D-42F9-8AE8-C11263A2CC5AQ57074754-936705CE-FA4B-41B9-BC52-F748CFD0F089
P2860
Development and Characterization of Monoclonal Antibodies Specific for Mouse and Human Fcγ Receptors.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Development and Characterizati ...... Mouse and Human Fcγ Receptors.
@en
type
label
Development and Characterizati ...... Mouse and Human Fcγ Receptors.
@en
prefLabel
Development and Characterizati ...... Mouse and Human Fcγ Receptors.
@en
P2093
P356
P1476
Development and Characterizati ...... Mouse and Human Fcγ Receptors.
@en
P2093
Alexander Earley
Ali Roghanian
Alison L Tutt
Andrew T Vaughan
Bjorn Frendéus
C Ian Mockridge
Christine A Penfold
Elizabeth A Potter
H T Claude Chan
P304
P356
10.4049/JIMMUNOL.1402988
P407
P50
P577
2015-10-28T00:00:00Z